EZH2 and neoplasm: EZH2 was chosen as a relevant positive control because of its well-characterized role in a wide range of tumor types19,20 and the relevance of both loss- and gain-of-function mutations in myelodysplasias21–24, making it especially relevant for HSPC editing.